Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 10.1007/s00259-020-04944-2)

Document Type

Response or Comment

Publication Title

European Journal of Nuclear Medicine and Molecular Imaging

ISSN

16197070

PubMed ID

32918575

Publisher

Springer Link

School

School of Medical and Health Sciences

Funders

Metro North Office of Research Avant Mutual Group Pty Ltd

Comments

Roberts, M. J., Morton, A., Donato, P., Kyle, S., Pattison, D. A., Thomas, P., ... Yaxley, J. (2021). Correction to: 68 Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48, 655-656. https://doi.org/10.1007/s00259-020-04983-9

Abstract

© 2020, Springer-Verlag GmbH Germany, part of Springer Nature. Figure 2b is incorrect in the original paper.

DOI

10.1007/s00259-020-04983-9

Access Rights

free_to_read

Link to Full Text

Share

 
COinS
 

Link to publisher version (DOI)

10.1007/s00259-020-04983-9